Health

Enhertu Plus Pertuzumab Approved in the US as First New Treatment in a Decade for the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

DailyTrendDailyTrend
Dec 16, 2025 - 08:00
 0  1
December 15, 2025 -- AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or metastatic HER2-positive breast...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Emergency Response Safety Kit Recall: Airlife Removes Certain Broselow Pediatric Emergency Rainbow Tapes and Broselow ALS Organizers

Emergency Response Safety Kit Recall: Airlife Removes C...

DailyTrend Feb 12, 2026  0  0

RFK Jr. Allies Target States to Overturn Vaccine Mandates for Schools

RFK Jr. Allies Target States to Overturn Vaccine Mandat...

DailyTrend Feb 17, 2026  0  1

Keytruda and Keytruda Qlex, Plus Paclitaxel ± Bevacizum...

DailyTrend Feb 12, 2026  0  1

FDA Approves Yuvezzi (carbachol and brimonidine tartrat...

DailyTrend Jan 30, 2026  0  1

Glucose Monitor Sensor Recall: Abbott Diabetes Care Removes Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors

Glucose Monitor Sensor Recall: Abbott Diabetes Care Rem...

DailyTrend Feb 12, 2026  0  0

4 Months Trapped in a Hospital for an Obsolete Way of Treating Their Disease

4 Months Trapped in a Hospital for an Obsolete Way of T...

DailyTrend Feb 12, 2026  0  0